122 related articles for article (PubMed ID: 11591153)
1. The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
Shi L; Simpson MM; Ballesteros JA; Javitch JA
Biochemistry; 2001 Oct; 40(41):12339-48. PubMed ID: 11591153
[TBL] [Abstract][Full Text] [Related]
2. The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
Javitch JA; Shi L; Simpson MM; Chen J; Chiappa V; Visiers I; Weinstein H; Ballesteros JA
Biochemistry; 2000 Oct; 39(40):12190-9. PubMed ID: 11015197
[TBL] [Abstract][Full Text] [Related]
3. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.
Javitch JA; Ballesteros JA; Weinstein H; Chen J
Biochemistry; 1998 Jan; 37(4):998-1006. PubMed ID: 9454590
[TBL] [Abstract][Full Text] [Related]
4. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.
Javitch JA; Ballesteros JA; Chen J; Chiappa V; Simpson MM
Biochemistry; 1999 Jun; 38(25):7961-8. PubMed ID: 10387039
[TBL] [Abstract][Full Text] [Related]
5. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice.
Javitch JA; Fu D; Chen J
Biochemistry; 1995 Dec; 34(50):16433-9. PubMed ID: 8845371
[TBL] [Abstract][Full Text] [Related]
6. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice.
Fu D; Ballesteros JA; Weinstein H; Chen J; Javitch JA
Biochemistry; 1996 Sep; 35(35):11278-85. PubMed ID: 8784181
[TBL] [Abstract][Full Text] [Related]
7. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method.
Javitch JA; Fu D; Chen J; Karlin A
Neuron; 1995 Apr; 14(4):825-31. PubMed ID: 7718244
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
9. A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice.
Javitch JA; Li X; Kaback J; Karlin A
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10355-9. PubMed ID: 7937955
[TBL] [Abstract][Full Text] [Related]
10. The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice.
Shi L; Javitch JA
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):440-5. PubMed ID: 14704269
[TBL] [Abstract][Full Text] [Related]
11. The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.
Xu W; Campillo M; Pardo L; Kim de Riel J; Liu-Chen LY
Biochemistry; 2005 Dec; 44(49):16014-25. PubMed ID: 16331961
[TBL] [Abstract][Full Text] [Related]
12. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.
Nebane NM; Hurst DP; Carrasquer CA; Qiao Z; Reggio PH; Song ZH
Biochemistry; 2008 Dec; 47(52):13811-21. PubMed ID: 19053233
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the TM1-TM2 loop contributes to the rho1 GABA receptor pore.
Filippova N; Wotring VE; Weiss DS
J Biol Chem; 2004 May; 279(20):20906-14. PubMed ID: 15007065
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments.
Simpson MM; Ballesteros JA; Chiappa V; Chen J; Suehiro M; Hartman DS; Godel T; Snyder LA; Sakmar TP; Javitch JA
Mol Pharmacol; 1999 Dec; 56(6):1116-26. PubMed ID: 10570038
[TBL] [Abstract][Full Text] [Related]
15. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.
Ballesteros JA; Shi L; Javitch JA
Mol Pharmacol; 2001 Jul; 60(1):1-19. PubMed ID: 11408595
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptors form higher order oligomers at physiological expression levels.
Guo W; Urizar E; Kralikova M; Mobarec JC; Shi L; Filizola M; Javitch JA
EMBO J; 2008 Sep; 27(17):2293-304. PubMed ID: 18668123
[TBL] [Abstract][Full Text] [Related]
17. Structural organization and interactions of transmembrane domains in tetraspanin proteins.
Kovalenko OV; Metcalf DG; DeGrado WF; Hemler ME
BMC Struct Biol; 2005 Jun; 5():11. PubMed ID: 15985154
[TBL] [Abstract][Full Text] [Related]
18. The substituted-cysteine accessibility method (SCAM) to elucidate membrane protein structure.
Liapakis G; Simpson MM; Javitch JA
Curr Protoc Neurosci; 2001 May; Chapter 4():Unit 4.15. PubMed ID: 18428478
[TBL] [Abstract][Full Text] [Related]
19. Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 65 in helix TM1 and residues in the sequence 306-319 at the cytoplasmic end of helix TM7 and in helix H8.
Altenbach C; Cai K; Klein-Seetharaman J; Khorana HG; Hubbell WL
Biochemistry; 2001 Dec; 40(51):15483-92. PubMed ID: 11747423
[TBL] [Abstract][Full Text] [Related]
20. Identification of transmembrane domain 1 & 2 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.
Sainsily X; Cabana J; Holleran BJ; Escher E; Lavigne P; Leduc R
Biochem Pharmacol; 2014 Nov; 92(2):280-8. PubMed ID: 25175740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
